Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaccine

Showing results (1-10 of 29,244) with videos related to

Pageof 2,925
Sort By:
Vaccine|September 6, 2001
Report on the Third Annual Walker's Cay colloquium on cancer vaccinesA L Goldstein
Vaccine|September 6, 2001
Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccineM Fiedler, M Lu, F Siegel, et al.
Vaccine|September 6, 2001
Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infantsM L Clements-Mann, R Dudas, Y Hoshino, et al.
Vaccine|September 6, 2001
A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adultsR W Joines, M Blatter, B Abraham, et al.
Vaccine|September 6, 2001
Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinantG Sinnathamby, G J Renukaradhya, M Rajasekhar, et al.
Vaccine|June 28, 2001
Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21D C Waite, E W Jacobson, F A Ennis, et al.
Vaccine|June 28, 2001
Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunizationJ J Shieh, C M Liang, C Y Chen, et al.
Vaccine|April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjectsJ S Lambert, M Keefer, M J Mulligan, et al.
Vaccine|April 20, 2001
Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controlsR Borrow, J Southern, N Andrews, et al.
Vaccine|April 20, 2001
Long-term persistence of cellular immunity to Oka vaccine virus induced by pernasal co-administration with Escherichia coli enterotoxin in miceN Kamiya, Y Asano, J Yoshino, et al.
Pageof 2,925

Showing results (1-10 of 29,244) with videos related to

Sort By:
Pageof 2,925
Vaccine|September 6, 2001
Report on the Third Annual Walker's Cay colloquium on cancer vaccinesA L Goldstein
Vaccine|September 6, 2001
Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccineM Fiedler, M Lu, F Siegel, et al.
Vaccine|September 6, 2001
Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infantsM L Clements-Mann, R Dudas, Y Hoshino, et al.
Vaccine|September 6, 2001
A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adultsR W Joines, M Blatter, B Abraham, et al.
Vaccine|September 6, 2001
Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinantG Sinnathamby, G J Renukaradhya, M Rajasekhar, et al.
Vaccine|June 28, 2001
Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21D C Waite, E W Jacobson, F A Ennis, et al.
Vaccine|June 28, 2001
Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunizationJ J Shieh, C M Liang, C Y Chen, et al.
Vaccine|April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjectsJ S Lambert, M Keefer, M J Mulligan, et al.
Vaccine|April 20, 2001
Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controlsR Borrow, J Southern, N Andrews, et al.
Vaccine|April 20, 2001
Long-term persistence of cellular immunity to Oka vaccine virus induced by pernasal co-administration with Escherichia coli enterotoxin in miceN Kamiya, Y Asano, J Yoshino, et al.
Pageof 2,925